New imaging protocol enhances visualization of rare bone marrow cells
View as a Web Page
News Medical
 
  Hematology Hematology logo  
  The latest hematology news from News Medical  
 Researchers create an atlas of health associations for GLP-1 receptor agonistsResearchers create an atlas of health associations for GLP-1 receptor agonists
 
Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for gastrointestinal and musculoskeletal issues.
 
 
 New imaging protocol enhances visualization of rare bone marrow cellsNew imaging protocol enhances visualization of rare bone marrow cells
 
Bone marrow plays a crucial role in maintaining hematopoietic stem cells and bone homeostasis. However, research has been hindered by a lack of effective markers and monoclonal antibodies to accurately identify rare LepR+ stromal cells.
 
   Antidepressant fluoxetine found ineffective for early COVID-19 treatmentAntidepressant fluoxetine found ineffective for early COVID-19 treatment
 
Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.
 
   Study uncovers distinct blood protein signature in children with Long COVIDStudy uncovers distinct blood protein signature in children with Long COVID
 
Distinct protein profiles linked to inflammation and angiogenesis found in children with Long COVID, paving the way for improved diagnostics and therapies.
 
   Microplastics in the bloodstream may pose hidden risks to brain healthMicroplastics in the bloodstream may pose hidden risks to brain health
 
Trapped immune cells laden with microplastics starve the brain of oxygen—mouse study links vascular blockages to memory loss and motor deficits, with lingering risks even after symptoms fade.
 
 AI model predicts blood transfusion needs in ICU patients
 
AI model predicts blood transfusion needs in ICU patientsResearchers at Emory University have developed a groundbreaking artificial intelligence (AI) model capable of accurately predicting the likelihood of blood transfusion in non-traumatic intensive care unit (ICU) patients.
 
 
 New diagnostic device could enable at-home early bladder cancer detection
 
New diagnostic device could enable at-home early bladder cancer detectionInnovative fluorescence-based diagnostic system identifies early-stage bladder cancer with 90% accuracy, utilizing untreated urine samples for at-home testing.
 
 
 New AI model predicts gene expression across human cell types
 
New AI model predicts gene expression across human cell typesA team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia University have created an artificial intelligence model that can predict which genes are expressed in any type of human cell.
 
 
 T cells grown with new technique offer better cancer defense
 
T cells grown with new technique offer better cancer defenseResearchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared to those grown in traditional growth media.
 
 
 What is an Orphan Drug? A Guide to Rare Disease Therapies
 
What is an Orphan Drug? A Guide to Rare Disease TherapiesOrphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and driving advancements in pharmaceuticals.
 
 
 Breakthrough gene discovery offers new hope for medulloblastoma therapy
 
Breakthrough gene discovery offers new hope for medulloblastoma therapyScientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.
 
 
 New urine-based kit promises accurate bladder cancer diagnosis at home
 
New urine-based kit promises accurate bladder cancer diagnosis at homeBladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring.
 
 
 Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients
 
Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patientsAbelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and efficacy. While ischemic stroke rates were slightly higher, they were not statistically significant, warranting further phase 3 trials for confirmation.
 
 
 Brain-Computer Interfaces: What They Are and Why They Matter
 
Brain-Computer Interfaces: What They Are and Why They MatterBrain-computer interfaces translate neural signals into actions, revolutionizing healthcare and enhancing communication for individuals with disabilities.
 
 
 Real-world effectiveness and safety of olaparib in HRD-positive BRCA wild-type ovarian cancer
 
Real-world effectiveness and safety of olaparib in HRD-positive BRCA wild-type ovarian cancerOvarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting following first-line chemotherapy.
 
 
 New approach uses peptides to enhance anti-tumor drug formulations
 
New approach uses peptides to enhance anti-tumor drug formulationsA team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.
 
 
 Oral fecal transplantation could help prevent graft-versus-host disease in stem cell transplant patients
 
Oral fecal transplantation could help prevent graft-versus-host disease in stem cell transplant patientsA new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood cancers.
 
 
 Researchers develop T cell growth method that enhances cancer-fighting ability in melanoma model
 
Researchers develop T cell growth method that enhances cancer-fighting ability in melanoma modelFindings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.
 
 
 Researchers compare cow and camel milk proteomes, focusing on immune proteins and processing
 
Researchers compare cow and camel milk proteomes, focusing on immune proteins and processingThis study compares immune proteins and bioactive peptides in cow and camel milk, highlighting camel milk's lower allergenic potential and therapeutic benefits.
 
 
 Immune environment found to influence success of leukemia immunotherapy
 
Immune environment found to influence success of leukemia immunotherapyA research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field of cancer immunotherapy.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025